Polymyalgia rheumatica treatment varies significantly in glucocorticoid dosages, tapering strategies and DMARD use. EULAR and ACR have published treatment recommendations. In this slideshow, we highlight the recommendations.
In this month's health quiz, we revisit some of our most popular articles published in recent weeks. This includes news reports on the safety and efficacy of baricitinib, upadacitinib effectiveness as monotherapy, inherited rheumatoid arthritis and our most popular story from this month: The sexual health of patients with musculoskeletal conditions.
In this slideshow, Dr. Kim Gorgens makes recommendations for incorpating sexual function complications as part of the discussion in a clinic exam.
EULAR has issued new treatment guidelines for antiphospholipid syndrome, a disorder of the immune system that causes blood clots. Among the recommendations, high risk individuals who carry the antiphospholipid antibody should take low-dose aspirin, even if they are asymptomatic. This also applies to systemic lupus erythematosus patients and women with a history of obstetric antiphospholipid syndrome.
Researchers writing in Arthritis Research & Therapy have outlined some factors that influence DNA methylation, also known as epigentics. In this slideshow, we highlight the factors.
In this slideshow, we revisit some of the most notable research findings in rheumatology featured in recent weeks. We begin with a study that shows TNF inhibitor treatment may not heighten cancer risk.
The questions patients ask sometimes differ from the questions doctors want them to ask, find researchers reporting in Arthritis Care & Research. In this slideshow, we compare the top five questions patients ask after an osteoarthritis diagnosis to the top five questions doctors had in mind.
In this installment of our psoriatic arthritis quiz series, we focus on phenotypes unique to psoriatic arthritis. We also include a question or two on other issues that may stump you.
EULAR 2019 wraps this weekend in Madrid. In this slideshow, we highlight some of the most noteworthy findings, beginning with a possible new treatment combination for patients who have both gout and kidney disease.
A study published last month in Arthritis Care & Research shows that racial/ethnic minorities disproportionately have more severe cases of systemic lupus erythematosus (SLE). In this slideshow, we summarize the findings, but we'd like to know what you think. Email us your comments at [email protected].